Citi Upgrades McKesson (MCK) to Buy; Discounting Rx Margin Compression

March 17, 2009 10:38 AM EDT Send to a Friend
Citi upgrades McKesson Corp (NYSE: MCK) from Hold to Buy. Price target $44.

Citi analyst says, "The majority ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login